INIS
bacteria
11%
biopsy
19%
bones
19%
breasts
27%
cancer
46%
children
8%
communities
14%
covid-19
8%
data
8%
dendrites
13%
density
7%
diseases
38%
education
12%
etiology
10%
evaluation
14%
females
10%
humans
11%
implants
20%
injuries
22%
interactions
10%
levels
10%
lymph nodes
11%
lymphomas
100%
males
13%
men
15%
metastases
13%
morphology
9%
mutations
11%
neoplasms
15%
nmr imaging
9%
pain
12%
pathogens
10%
pathology
34%
patients
96%
processing
8%
proposals
14%
prostate
27%
proteins
8%
reviews
55%
risks
15%
spectra
9%
spinal cord
17%
stains
10%
surgery
16%
therapy
8%
tissues
11%
tools
8%
tumors
40%
values
12%
volume
10%
Medicine and Dentistry
Age
9%
Analysis
23%
Anaplastic Large Cell Lymphoma
20%
Angiofollicular Lymph Node Hyperplasia
13%
Biopsy
13%
Bladder
6%
Bone
13%
Bone Marrow
8%
Breast Implant
13%
Case Report
30%
Classical Hodgkin Lymphoma
13%
Comprehension
17%
COVID-19
11%
Diagnosis
47%
Disease
14%
Etiology
9%
Evaluation Study
10%
Experience
19%
Female
9%
Fine-Needle Aspiration
9%
Flow Cytometry
20%
Hematopathology
14%
Hemolytic Anemia
6%
Hispanic
12%
Hodgkin's Lymphoma
8%
Human Herpesvirus 8
9%
Immunohistochemistry
13%
Infarction
6%
Inpatient
17%
Large-Cell Lymphoma
8%
Lesion
17%
Light Chain
6%
Lymphoma
11%
Malignant Neoplasm
13%
Man
13%
Morphology
16%
Neoplasm
27%
Non-Hodgkin Lymphoma
7%
Pain
6%
Pathology
15%
Patient
56%
Plasmablastic Lymphoma
7%
Plasmacytoid Dendritic Cell
10%
Prognosis
11%
Prostate Cancer
27%
Prostatectomy
7%
Recognition
13%
Specimen
10%
Spleen
6%
Therapeutic Procedure
7%
Keyphrases
ALK+
6%
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
6%
Bone Lymphoma
6%
Breast Implant Capsules
6%
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
6%
Castleman Disease
6%
Complex Variants
6%
Cycle Inhibiting Factor
6%
Dedifferentiated Liposarcoma
6%
Diagnostic Components
6%
Dual Expression
6%
Fibrotic Scar
6%
Future of Education
6%
Galveston
6%
Hematogones
6%
Hematopathologist
6%
Hemolytic Anemia
6%
High-intensity Focused Ultrasound Therapy
5%
Histopathology Images
6%
Kidney Mass
6%
Leukemic Presentation
6%
Myopathy
6%
Neurological Dysfunction
6%
NG2 Glia
6%
Novel Variants
6%
Pathomorphology
6%
Perforin-2
6%
Perivascular Fibroblasts
6%
Phosphoglycerate Kinase 1 (PGK1)
6%
Primary non-Hodgkin's Lymphoma
6%
PSA Mass
6%
Pseudofungi
6%
Rebranding
6%
Rhabdomyoblastic Differentiation
6%
Richter Syndrome
6%
Template Biopsy
6%
Variant Translocation
6%
Very-low-risk Prostate Cancer
6%
